19. Mechetner EB, Roninson IB (1992) Efficient inhibition of P-glycoprotein- mediated multidrug resistance with a monoclonal antibody. Proc Natl Acad Sci USA 89: 5824–5828. 20. Darland DC, D’Amore PA (2001) Cell–cell interactions in vascular develop- ment. Curr Top Dev Biol 52: 107–149. 21. Batista FD, Iber D, Neuberger MS (2001) B cells acquire antigen from target cells after synapse formation. Nature 411: 489–494. 22. Espinosa E, Tabiasco J, Hudrisier D, Fournie JJ (2001) Synaptic transfer by human gamma delta T cells stimulated with soluble or cellular antigens. J Immunol 166: 3645–3649. 23. Poupot M, Pont F, Fournie JJ (2005) Profiling blood lymphocyte interactions with cancer cells uncovers the innate reactivity of human gamma delta T cells to anaplastic large cell lymphoma. J Immunol 174: 1717–1722. 24. Naniwa J, Kigawa J, Kanamori Y, Itamochi H, Oishi T, et al. (2007) Genetic diagnosis for chemosensitivity with drug-resistance genes in epithelial ovarian cancer. Int J Gynecol Cancer 7: 76–82. 25. Yakirevich E, Sabo E, Naroditsky I, Sova Y, Lavie O, et al. (2006) Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas. Gynecol Oncol 100: 152–159. 26. Sako A, Kitayama J, Shida D, Suzuki R, Sakai T, et al. (2006) Lysophosphatidic acid (LPA)-induced vascular endothelial growth factor (VEGF) by mesothelial cells and quantification of host-derived VEGF in malignant ascites. J Surg Res 130: 94–101. 27. Rodriguez-Rodriguez L, Sancho-Torres I, Mesonero C, Gibbon DG, Shih WJ, et al. (2003) The CD44 receptor is a molecular predictor of survival in ovarian cancer. Med Oncol 20: 255–63. 28. Rodriguez GC, Haisley C, Hurteau J, Moser TL, Whitaker R, Bast, et al. (2001) Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta. Gynecol Oncol 80: 245–53. 29. Jayne DG, Perry SL, Morrison E, Farmery SM, Guillou PJ (2000) Activated mesothelial cells produce heparin-binding growth factors: implications for tumour metastases. Br J Cancer 82: 1233–8. 30. Betjes MG, Tuk CW, Struijk DG, Krediet RT, Arisz L, et al. (1993) Interleukin- 8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-alpha, interleukin-1, and medium conditioned by macrophages cocul- tured with Staphylococcus epidermidis. J Infect Dis 168: 1202–10. 31. Scha¨ffler A, Bu¨chler C (2007) Concise review: adipose tissue-derived stromal cells–basic and clinical implications for novel cell-based therapies. Stem Cells 25: 818–27. 32. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, et al. (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557–563. 33. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, et al. (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre- metastatic niche. Nature 438: 820–827. 34. Wels J, Kaplan RN, Rafii S, Lyden D (2008) Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev 22: 559–74. 35. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, et al. (2001) The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7: 1028–34. Oncologic Trogocytosis 36. Boucheix C, Rubinstein E (2001) Tetraspanins. Cell Mol Life Sci 58(9): 1189–205. 37. Hemler ME (2005) Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 6(10): 801–11. 38. Levy S, Shoham T (2005) The tetraspanin web modulates immune-signalling complexes. Nat Rev Immunol 5(2): 136–48. 39. Houle CD, Ding XY, Foley JF, Afshari CA, Barrett JC, Davis BJ (2002) Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovarian cancer progression. Gynecol Oncol 86(1): 69–7. 40. Velasquez EF, Yancovitz M, Pavlick A, Berman R, Shapiro R, et al. (2007) Clinical relevance of Neutral Endopeptidase (NEP/CD10) in melanoma. Journal of Translational Medicine 5(2): 2. 41. Khin EE, Kikkawa F, Ino K, Suzuki T, Shibata K, et al. (2003) Neutral endopeptidase/CD10 expression in the stroma of epithelial ovarian carcinoma. Int J Gynecol Pathol 22(2): 175–80. 42. Mezzanzanica D, Fabbi M, Bagnoli M, Staurengo S, Losa M, et al. (2008) Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients. Clin Cancer Res 14(6): 1726–33. 43. Seshi B, Kumar S, Sellers D (2000) Human bone marrow stromal cell: coexpression of markers specific for multiplemesenchymal cell lineages. Blood Cells Mol Dis 26(3): 234–46. 44. Guezguez B, Vigneron P, Lamerant N, Kieda C, Jaffredo T, Dunon D (2007) Dual Role of Melanoma Cell Adhesion Molecule (MCAM)/CD146 in Lymphocyte Endothelium Interaction: MCAM/CD146 Promotes Rolling via Microvilli Induction in Lymphocyte and Is an Endothelial Adhesion Receptor. J Immunol 179(10): 6673–85. 45. Shih IM, Wang TL, Westra WH (1996) Diagnostic and biological implications of mel-CAM expression in mesenchymal neoplasms. Clin Cancer Res 2(3): 569–75. 46. Zannettino AC, Paton S, Arthur A, Khor F, Itescu S, et al. (2008) Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol 214(2): 413–21. 47. Levchenko A, Mehta BM, Niu X, Kang G, Villafania L (2005) Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells. Proc Natl Acad Sci USA 102: 1933–1938. 48. Joly E, Hudrisier D (2003) What is trogocytosis and what is its purpose? Nat Immunol 4: 815. 49. Davis DM (2007) Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response. Nat Rev Immunol 7: 238–243. 50. Galon J, Fridman WH, Pages F (2007) The adaptive immunologic microenvi- ronment in colorectal cancer: a novel perspective. Cancer Res 67: 1883–1886. 51. Bendayan M, Nanci A, Kan FW (1987) Effect of tissue processing on colloidal gold cytochemistry. J Histochem Cytochem 35: 983–996. 52. Smith JA, Ngo H, Martin MC, Wolf JK (2005) An evaluation of cytotoxicity of the taxane and platinum agents combination treatment in a panel of human ovarian carcinoma cell lines. Gynecol Oncol 98: 141–145. 53. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107–1112. 54. Poupot M, Fournie JJ (2003) Membrane transfer through homotypic synapses between lymphoma cells. J Immunol 171: 2517–2523. PLoS ONE | www.plosone.org 13 December 2008 | Volume 3 | Issue 12 | e3894